Notice of Intent to Sole Source: Vaccine Adverse Event Reporting System (VAERS) & Safety Monitoring Support
Key Takeaways
- Set-aside for 8(a) Set-Aside businesses
- Work to be performed in Rockville, MD
- Industry: Research and Development in the Social Sciences and Humanities
Contract Details
- Notice ID
- CBER-2026-133723
- Opportunity Type
- Special Notice
- Sub-Agency
- FOOD AND DRUG ADMINISTRATION
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Posted Date
- Thursday, September 10, 2026
- Response Deadline
- Friday, September 18, 2026
- PSC Code
- AJ11
- Set-Aside
- 8(a) Set-Aside
- Place of Performance
- Rockville, MD, 20852
- Status
- Active
Description
The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER)s Office of Biostatistics and Pharmacovigilance (OPBV)s Division of Pharmacovigilance (DPV) is responsible for monitoring the safety of vaccines and biologics once they are approved for use under a Biologic Licensing Application (BLA) or authorized for use under an Emergency Use Authorization (EUA). The Contractor shall furnish the necessary services and qualified personnel needed to perform the Statement of Work.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in the social sciences and humanities with a set-aside for 8(a) Set-Aside businesses in Rockville, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
